Basic fibroblast growth factor affects the expression of angiogenin and cell proliferation in A375 human melanoma cells

Tumori

Volumn 97, Issue 1, 2011, Pages 95-103

  Zhao, Jia ^a   Yang, Qiong ^a   Yang, Jianli ^a   Wang, Ji ^a   Fan, Lingling ^a   Wang, Li ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

A375 cells; Angiogenin; bFGF; Cell proliferation; Protein expression

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ARTICLE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MELANOMA CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANGIOGENESIS INDUCING AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER;

EID: 79953876021     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/611.7145     Document Type: Article

References (42)

1. Bevona C, Sober AJ: Melanoma incidence trends. Dermatol Clin, 20: 589-595, 2002.
2. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol, 145: 510-514, 1994.
3. Rofstad EK, Halsor EF: Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis andmetastasis in humanmelanoma xenografts. Cancer Res, 60: 4932-4938, 2000.
4. Bikfaivi A, Klein S, Pintucci G, Rilkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev, 18: 26-45, 1997.
5. Moscatelli D, Presta M, Rifkin DB: Purification of a factor from human placenta that stimulates endothelial cell protease production, DNA synthesis and migration. Proc Natl Acad Sci USA, 83: 2091-2095, 1986.
6. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, Rifkin DB: Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell, 4: 973-982, 1993.
7. Klein S, Bikfalvi A, Birkenmeier TM, Giancotti FG, Rifkin DB: Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J Biol Chem, 271: 22583-22590, 1996.
8. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv. Cancer Res, 59: 115-165, 1992.
9. Becker D, Meier CB, Herlyn M: Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J, 8: 3685-3691, 1989.
10. Wang YP, Berker D: Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med, 3: 887-893, 1997.
11. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24: 5480-5486, 1985.
12. Olson KA, Byers HR, Key ME, Fett JW: Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res, 7: 3598-3605, 2001.
13. Olson KA, Byers HR, Key ME, Fett JW: Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer, 98: 923-929, 2002.
14. Olson KA, Fett JW, French TC, Key ME, Vallee BL: Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci USA, 92: 442-446, 1995.
15. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Bröcker E, Klein C: Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res, 59: 1578-1583, 1999.
16. Montero S, Guzman C, Cortes-Funes H, Colomer R: Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res, 4: 2161-2168, 1998.
17. Chopra V, Dinh TV, Hannigan EV: Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest, 16: 152-159, 1998.
18. Li D, Bell J, Brown A, Berry CL: The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol, 172: 171-175, 1994.
19. Shimoyama S, Shimizu N, Tsuji E, Yamasaki K, Kawahara M, Kaminishi M: Distribution of angiogenin and its gene message in colorectal cancer patients and their clinical relevance. Anticancer Res, 22: 1045-1052, 2002.
20. Chopra V, Dinh TV, Hannigan EV: Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol, 123: 167-172, 1997.
21. Shimoyama S, Kaminishi M: Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol, 126: 468-474, 2000.
22. Hisai H, Kato J, Kobune M, Murakami T, Miyanishi K, Takahashi M, Yoshizaki N, Takimoto R, Terui T, Niitsu Y: Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res, 9: 4852-4859, 2003.
23. Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E: Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res, 19: 1537-1540, 1999.
24. Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L: Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res, 11: 8358-8363, 2005.
25. Olson KA, French TC, Vallee BL, Fett JW: A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res, 54: 4576-4579, 1994.
26. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF: Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene, 22: 445-456, 2004.
27. Song J, Wang J, Yang J, Jiang C, Shen W, Wang L: Influence of angiogenin on the growth of A375 human melanoma cells and the expression of basic fibroblast growth factor. Melanoma Res, 6: 119-126, 2006.
28. Yang J, Wang J, Zhao J, Zuo D, Li X, Wang L: Influence of basic fibroblast growth factor on the growth of HeLa cells and the expression of angiogenin. Oncol Rep, 21: 949-955, 2009.
29. Wang J, Yang J, Yuan D, Wang J, Zhao J, Wang L: Effects of basic fibroblast growth factor on angiogenin expression and cell proliferation of H7402 human hepatoma cells. J Genet Genom, 36: 399-407, 2009.
30. Dorkin TJ, Robinson MC, Marsh C, Neal DE, Leung HY: aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8. J Pathol, 189: 564-569, 1999.
31. Liu X, Zheng SX, Zhou LJ, Zhu XZ: Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor in primary cultured rat astrocytes. Acta Pharmacol Sin, 21: 19-22, 2000.
32. Rabie AB, Lu M: Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft. Arch Oral Biol, 49: 1025-1033, 2004.
33. Yasuda E, Tokuda H, Ishisaki A, Hirade K, Kanno Y, Hanai Y, Nakamura N, Noda T, Katagiri Y, Kozawa O: PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts. Biochem Biophys Res Commun, 328: 137-143, 2005.
34. Xu ZP, Monti DM, Hu GF: Angiogenin activates human umbilical artery smooth muscle cells. Biochem Biophys Res Commun, 285: 909-914, 2001.
35. Widmann C, Gibson S, Jarpe MB: Mitogen activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev, 79: 143-180, 1999.
36. Kin M, Sata M, Ueno T, Torimura T, Inuzuka S, Tsuji R, Sujaku K, Sakamoto M, Sugawara H, Tamaki S, Tanikawa K: Basic fibroblast growth factor regulates proliferation and motility of human hepatoma cells by an autocrine mechanism. J Hepatol, 27: 677-687, 1997.
37. Sheng Z, Chang SB, Chirico WJ: Expression and purification of a biologically active basic fibroblast growth factor fusion protein. Protein Expr Purif, 27: 267-271, 2003.
38. Dailey L, Ambrosetti D, Mansukhani A, Basilico C: Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev, 16: 233-247, 2005.
39. Pederson T: Growth factors in the nucleolus? J Cell Biol, 143: 279-281, 1998.
40. Claus P, Doring F, Gringel S, Ostermeyer FM, Fuhlrott J, Kraft T, Grothe C: Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem, 278: 479-485, 2003.
41. Xu ZP, Tsuji T, Riordan JF, Hu GF: Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry, 42: 121-128, 2003.
42. Sheng Z, Lewis JA, Chirico WJ: Nuclear and nucleolar localization of 18 kDa fibroblast growth factor-2 is controlled by C-terminal signals. J Biol Chem, 279: 40153-40160, 2004.